共 50 条
Safety and efficacy of a new covered stent in hemodialysis vascular access outflow stenosis: A Brazilian multicenter retrospective study
被引:1
|作者:
Harduin, Leonardo de Oliveira
[1
]
Barroso, Thiago Almeida
[2
]
Guerra, Julia Bandeira
[3
,4
]
Filippo, Marcio Gomes
[5
]
de Almeida, Leonardo Cortizo
[6
]
Vieira, Brunno Ribeiro
[7
]
Mello, Renata Silveira
[8
]
Galhardo, Adriano Martins
[9
]
de Castro-Santos, Guilherme
[9
]
Virgini-Magalhaes, Carlos Eduardo
[10
]
Strogoff-de-Matos, Jorge Paulo
[11
]
机构:
[1] Liv Care Ctr Clin, Rua Miguel de Frias 88, BR-24220002 Niteroi, RJ, Brazil
[2] Afya Hosp Dia, Brasilia, DF, Brazil
[3] Hosp Niteroi Dor, Ctr Clin LIVCARE, Niteroi, RJ, Brazil
[4] Ctr Clin LIVCARE, Niteroi, RJ, Brazil
[5] Univ Fed Estado Rio de Janeiro UFRJ, Univ Fed Estado Rio Janeiro UFRJ, Vasc Surg Serv, Rio De Janeiro, RJ, Brazil
[6] Hosp Ana Nery, Vasc Surg Serv, Salvador, BA, Brazil
[7] Inst Nacl Traumatol & Ortopedia, Rio De Janeiro, RJ, Brazil
[8] Hosp Niteroi Dor, Vasc Surg Serv, Niteroi, RJ, Brazil
[9] Afya Ctr Acesso Vasc, Brasilia, DF, Brazil
[10] Univ Estado Rio de Janeiro, Univ Estado Rio Janeiro, Vasc & Endovasc Surg Dept, Rio De Janeiro, RJ, Brazil
[11] Univ Fed Fluminense, Dept Med, Div Nephrol, Niteroi, RJ, Brazil
来源:
JOURNAL OF VASCULAR ACCESS
|
2025年
/
26卷
/
02期
关键词:
Hemodialysis;
covered stent;
stent graft;
vascular access;
stenosis;
CEPHALIC ARCH STENOSIS;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
ARTERIOVENOUS-FISTULA;
GRAFT PLACEMENT;
PATENCY;
COMPLICATIONS;
DYSFUNCTION;
MANAGEMENT;
OUTCOMES;
D O I:
10.1177/11297298231226259
中图分类号:
R6 [外科学];
学科分类号:
1002 ;
100210 ;
摘要:
Background: Vascular stenosis commonly leads to dysfunction in hemodialysis vascular access. Although percutaneous transluminal angioplasty is an established treatment, stent utilization has increased in the last decade as an alternative solution to extend the access function. This study evaluated the safety and initial results of a new impermeable covered stent for treating vascular access outflow stenosis.Methods: Investigators retrospectively analyzed 114 hemodialysis patients treated with polytetrafluorethylene-covered stents from September 2018 to September 2022 across four centers. Lesions treated were de novo or restenotic and located in the venous graft anastomosis, outflow segment, cephalic arch, and basilic swing point. Patients were followed by in-person physical examination at 1, 3, and 6 months, and Duplex ultrasound was performed to evaluate the vascular access circuit and in-stent restenosis. The primary efficacy endpoint was target lesion primary patency at 1, 3, and 6 months. Secondary endpoints included access circuit primary patency and secondary patency at 1, 3, and 6 months. The primary safety endpoint was freedom from local or systemic serious adverse events through 30 days post-procedure.Results: Forty-four patients had thrombosed access at the initial presentation, and 41 patients presented with recurrent stenosis. The target lesion primary patency rates at 1, 3, and 6 months were 100%, 89.4%, and 74%, respectively. The access circuit primary patency rates were 100% at 1 month, 85% at 3 months, and 62.7% at 6 months. The secondary patency rates at 1, 3, and 6 months were 100%, 96.4%, and 94.6%, respectively. In the adjusted multivariate Cox regression analysis, only recurrent lesions and female gender were associated with reduced primary patency rates. No serious adverse event was observed through the first 30 days post-procedure.Conclusion: In this retrospective analysis, a new covered stent was shown to be safe and effective for treating peripheral outflow stenosis in vascular access.
引用
收藏
页码:510 / 518
页数:9
相关论文